Hi Richo
During the webinar of 29 Feb 24, Jon mentioned that the bar for the PH and Angelman p-values should be the Phase 3 Rett trial results (2021) and NOT the recent PMS results (as these results were so good, it may set the bar too high). I’ll post a screenshot of the 2021 p-values separately as HC never lets me post text and pics together.
Good luck everyone for the upcoming trial results - especially the patient populations.
Share Price, page-10192
-
- There are more pages in this discussion • 1,700 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.18 |
Change
-0.475(3.48%) |
Mkt cap ! $1.696B | |||
| Open | High | Low | Value | Volume |
| $13.68 | $13.68 | $13.12 | $2.707M | 202.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22 | $13.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.19 | 350 | 10 |
View Market Depth
| Last trade - 15.02pm 18/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |